PL2094653T3 - O-podstawione pochodne dibenzylomocznika jako antagoniści receptora TRPV1 - Google Patents

O-podstawione pochodne dibenzylomocznika jako antagoniści receptora TRPV1

Info

Publication number
PL2094653T3
PL2094653T3 PL07848984T PL07848984T PL2094653T3 PL 2094653 T3 PL2094653 T3 PL 2094653T3 PL 07848984 T PL07848984 T PL 07848984T PL 07848984 T PL07848984 T PL 07848984T PL 2094653 T3 PL2094653 T3 PL 2094653T3
Authority
PL
Poland
Prior art keywords
hydroxypropyl
pain
derivatives
substituted
receptor antagonists
Prior art date
Application number
PL07848984T
Other languages
English (en)
Inventor
Pier Giovanni Baraldi
Pier Andrea Borea
Pierangelo Geppetti
Francesca Fruttarolo
Maria Giovanna Pavani
Marcello Trevisani
Original Assignee
Pharmeste Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmeste Srl filed Critical Pharmeste Srl
Publication of PL2094653T3 publication Critical patent/PL2094653T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
    • C07C335/10—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C335/12—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL07848984T 2006-12-21 2007-12-06 O-podstawione pochodne dibenzylomocznika jako antagoniści receptora TRPV1 PL2094653T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06026533A EP1939173A1 (en) 2006-12-21 2006-12-21 O-substituted-dibenzyl urea- or thiourea- derivatives as trpv1 receptor antagonists
EP07848984A EP2094653B1 (en) 2006-12-21 2007-12-06 O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists
PCT/IB2007/003784 WO2008075150A1 (en) 2006-12-21 2007-12-06 O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists

Publications (1)

Publication Number Publication Date
PL2094653T3 true PL2094653T3 (pl) 2011-02-28

Family

ID=38139789

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07848984T PL2094653T3 (pl) 2006-12-21 2007-12-06 O-podstawione pochodne dibenzylomocznika jako antagoniści receptora TRPV1

Country Status (25)

Country Link
US (1) US7750049B2 (pl)
EP (2) EP1939173A1 (pl)
JP (1) JP5302214B2 (pl)
KR (1) KR101460177B1 (pl)
CN (1) CN101563317B (pl)
AT (1) ATE479652T1 (pl)
BR (1) BRPI0720421A2 (pl)
CA (1) CA2673219C (pl)
CY (1) CY1110833T1 (pl)
DE (1) DE602007008942D1 (pl)
DK (1) DK2094653T3 (pl)
EA (1) EA015152B1 (pl)
ES (1) ES2347492T3 (pl)
HR (1) HRP20100588T1 (pl)
IL (1) IL199422A (pl)
MX (1) MX2009006582A (pl)
NO (1) NO20092336L (pl)
NZ (1) NZ577796A (pl)
PL (1) PL2094653T3 (pl)
PT (1) PT2094653E (pl)
RS (1) RS51555B (pl)
SI (1) SI2094653T1 (pl)
UA (1) UA95986C2 (pl)
WO (1) WO2008075150A1 (pl)
ZA (1) ZA200904278B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009037707A2 (en) 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. N-phenyl anthranilic acid derivatives and uses thereof
US11123272B2 (en) 2016-12-02 2021-09-21 Symrise Ag Cosmetic blends
RU2755206C1 (ru) 2020-05-20 2021-09-14 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Средство пролонгированного анальгетического действия и лекарственный препарат на его основе

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8715357D0 (en) * 1987-06-30 1987-08-05 Sandoz Inst For Medical Resear Organic compounds
GB9519270D0 (en) * 1995-09-21 1995-11-22 Sandoz Pharma Uk Organic compounds
NZ523882A (en) * 2000-08-21 2004-11-26 Pacific Corp Novel thiourea derivatives and the pharmaceutical compositions containing the same
JP2003192660A (ja) * 2001-12-26 2003-07-09 Bayer Ag 尿素誘導体
US6858615B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
ITMI20041231A1 (it) * 2004-06-18 2004-09-18 Pharmeste Srl Antagonisti del recettore dei vanilloidi trpv1

Also Published As

Publication number Publication date
CA2673219A1 (en) 2008-06-26
CY1110833T1 (el) 2015-06-10
EP2094653B1 (en) 2010-09-01
US7750049B2 (en) 2010-07-06
SI2094653T1 (sl) 2011-01-31
PT2094653E (pt) 2010-09-23
EP1939173A1 (en) 2008-07-02
DE602007008942D1 (de) 2010-10-14
RS51555B (sr) 2011-06-30
EA015152B1 (ru) 2011-06-30
HRP20100588T1 (hr) 2010-12-31
CA2673219C (en) 2015-04-14
DK2094653T3 (da) 2010-10-25
ZA200904278B (en) 2010-08-25
US20100105740A1 (en) 2010-04-29
IL199422A (en) 2015-01-29
NZ577796A (en) 2011-10-28
MX2009006582A (es) 2009-07-02
ATE479652T1 (de) 2010-09-15
BRPI0720421A2 (pt) 2013-12-31
NO20092336L (no) 2009-06-18
WO2008075150A1 (en) 2008-06-26
EP2094653A1 (en) 2009-09-02
JP5302214B2 (ja) 2013-10-02
ES2347492T3 (es) 2010-10-29
CN101563317A (zh) 2009-10-21
UA95986C2 (uk) 2011-09-26
KR20090090347A (ko) 2009-08-25
JP2010513455A (ja) 2010-04-30
CN101563317B (zh) 2012-12-12
EA200900625A1 (ru) 2009-12-30
KR101460177B1 (ko) 2014-11-10

Similar Documents

Publication Publication Date Title
UA93872C2 (ru) Дигидротиенопиримидины для лечения воспалительных заболеваний
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
MX2008012915A (es) Dihidrotienopirimidinas para el tratamiento de enfermedades inflamatorias.
GEP20084439B (en) Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
MX2010004026A (es) Piperidino-dihidrotienopirimidinas sustituidas.
EA200900613A1 (ru) Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
EA200970287A1 (ru) Способы, соединения, композиции и носители, подходящие для доставки 3-амино-1-пропансульфоновой кислоты
PT1730146E (pt) Azaindoles úteis como inibidores de jak e outras proteínas quinases
EA201000805A1 (ru) Бис-(сульфониламино)производные в терапии 066
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
WO2007123939A3 (en) Novel arylamino n-heteraryls as mek inhibitors
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
SI1853602T1 (sl) Kemične spojine
PT1853588E (pt) Compostos químicos
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
IN2014MN00139A (pl)
EA201170795A1 (ru) Антагонисты ccr2 группы 4-азетидинил-1-гетероарил-циклогексанола
MX2009014001A (es) Derivados de isoxazol-imidazol.
DK1641454T3 (da) Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere
MX2024005292A (es) Polimorfos de la sal de clorhidrato de glurato de linaprazan.
SE0402925D0 (sv) Novel Compounds
ZA200904278B (en) O-Substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonists
SE0401763D0 (sv) Compounds
WO2006055434A3 (en) Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer&#39;s disease